376 related articles for article (PubMed ID: 30244038)
21. Molecular surveillance of carbapenemase-producing
Schäfer E; Malecki M; Tellez-Castillo CJ; Pfennigwerth N; Marlinghaus L; Higgins PG; Mattner F; Wendel AF
Antimicrob Resist Infect Control; 2019; 8():208. PubMed ID: 31893042
[TBL] [Abstract][Full Text] [Related]
22. In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa.
Hu YF; Liu CP; Wang NY; Shih SC
BMC Infect Dis; 2016 Aug; 16(1):444. PubMed ID: 27553962
[TBL] [Abstract][Full Text] [Related]
23. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea.
Cho HH; Kwon GC; Kim S; Koo SH
J Microbiol Biotechnol; 2015 Jul; 25(7):1154-62. PubMed ID: 25907063
[TBL] [Abstract][Full Text] [Related]
24. Dissemination of metallo-β-lactamase in Pseudomonas aeruginosa isolates in Egypt: mutation in blaVIM-4.
Hashem H; Hanora A; Abdalla S; Shaeky A; Saad A
APMIS; 2017 May; 125(5):499-505. PubMed ID: 28295668
[TBL] [Abstract][Full Text] [Related]
25. Inactivation of the oprD porin gene by a novel insertion sequence ISPa195 associated with large deletion in a carbapenem-resistant Pseudomonas aeruginosa clinical isolate.
Bocharova Y; Savinova T; Shagin DA; Shelenkov AA; Mayanskiy NA; Chebotar IV
J Glob Antimicrob Resist; 2019 Jun; 17():309-311. PubMed ID: 30684654
[TBL] [Abstract][Full Text] [Related]
26. Antimicrobial Susceptibility of Pseudomonas aeruginosa Isolated from Cystic Fibrosis Patients in Northern Europe.
Mustafa MH; Chalhoub H; Denis O; Deplano A; Vergison A; Rodriguez-Villalobos H; Tunney MM; Elborn JS; Kahl BC; Traore H; Vanderbist F; Tulkens PM; Van Bambeke F
Antimicrob Agents Chemother; 2016 Nov; 60(11):6735-6741. PubMed ID: 27572406
[TBL] [Abstract][Full Text] [Related]
27. VIM-1, VIM-2, and GES-5 Carbapenemases Among Pseudomonas aeruginosa Isolates at a Tertiary Hospital in Istanbul, Turkey.
Malkoçoğlu G; Aktaş E; Bayraktar B; Otlu B; Bulut ME
Microb Drug Resist; 2017 Apr; 23(3):328-334. PubMed ID: 27326514
[TBL] [Abstract][Full Text] [Related]
28. [Integron diversity in bla
Savinova TA; Bocharova YA; Lazareva AV; Chebotar IV; Mayanskiy NA
Klin Lab Diagn; 2019; 64(8):497-502. PubMed ID: 31479607
[TBL] [Abstract][Full Text] [Related]
29. Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain.
Del Barrio-Tofiño E; López-Causapé C; Cabot G; Rivera A; Benito N; Segura C; Montero MM; Sorlí L; Tubau F; Gómez-Zorrilla S; Tormo N; Durá-Navarro R; Viedma E; Resino-Foz E; Fernández-Martínez M; González-Rico C; Alejo-Cancho I; Martínez JA; Labayru-Echverria C; Dueñas C; Ayestarán I; Zamorano L; Martinez-Martinez L; Horcajada JP; Oliver A
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874376
[TBL] [Abstract][Full Text] [Related]
30. Identification and genetic characterization of metallo-beta-lactamase-producing strains of Pseudomonas aeruginosa in Tehran, Iran.
Shahcheraghi F; Nikbin VS; Feizabadi MM
New Microbiol; 2010 Jul; 33(3):243-8. PubMed ID: 20954442
[TBL] [Abstract][Full Text] [Related]
31. Determination of extended spectrum beta-lactamases, metallo-beta-lactamases and AmpC-beta-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
Neyestanaki DK; Mirsalehian A; Rezagholizadeh F; Jabalameli F; Taherikalani M; Emaneini M
Burns; 2014 Dec; 40(8):1556-61. PubMed ID: 24767143
[TBL] [Abstract][Full Text] [Related]
32. Molecular Characteristics of GES-Type Carbapenemase-Producing
Hong JS; Choi N; Kim SJ; Choi KH; Roh KH; Lee S
Microb Drug Resist; 2020 Jun; 26(6):605-610. PubMed ID: 31800356
[TBL] [Abstract][Full Text] [Related]
33. Distribution of carbapenem resistance mechanisms in Pseudomonas aeruginosa isolates among hospitalised children in Poland: Characterisation of two novel insertion sequences disrupting the oprD gene.
Wołkowicz T; Patzer JA; Kamińska W; Gierczyński R; Dzierżanowska D
J Glob Antimicrob Resist; 2016 Dec; 7():119-125. PubMed ID: 27750158
[TBL] [Abstract][Full Text] [Related]
34. Characterisation of VIM-2-producing Pseudomonas aeruginosa isolates from lower tract respiratory infections in a Spanish hospital.
Bellés A; Bueno J; Rojo-Bezares B; Torres C; Javier Castillo F; Sáenz Y; Seral C
Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1847-1856. PubMed ID: 29978304
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries.
Castanheira M; Deshpande LM; Costello A; Davies TA; Jones RN
J Antimicrob Chemother; 2014 Jul; 69(7):1804-14. PubMed ID: 24603963
[TBL] [Abstract][Full Text] [Related]
36. Investigating of four main carbapenem-resistance mechanisms in high-level carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
Rostami S; Farajzadeh Sheikh A; Shoja S; Farahani A; Tabatabaiefar MA; Jolodar A; Sheikhi R
J Chin Med Assoc; 2018 Feb; 81(2):127-132. PubMed ID: 29033110
[TBL] [Abstract][Full Text] [Related]
37. Occurrence of intI1-associated VIM-5 carbapenemase and co-existence of all four classes of β-lactamase in carbapenem-resistant clinical Pseudomonas aeruginosa DMC-27b.
Jahan MI; Rahaman MM; Hossain MA; Sultana M
J Antimicrob Chemother; 2020 Jan; 75(1):86-91. PubMed ID: 31647552
[TBL] [Abstract][Full Text] [Related]
38. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa clinical strains isolated from western Algeria between 2009 and 2012.
Sefraoui I; Berrazeg M; Drissi M; Rolain JM
Microb Drug Resist; 2014 Apr; 20(2):156-61. PubMed ID: 24320688
[TBL] [Abstract][Full Text] [Related]
39. Alterations of OprD in carbapenem-intermediate and -susceptible strains of Pseudomonas aeruginosa isolated from patients with bacteremia in a Spanish multicenter study.
Ocampo-Sosa AA; Cabot G; Rodríguez C; Roman E; Tubau F; Macia MD; Moya B; Zamorano L; Suárez C; Peña C; Domínguez MA; Moncalián G; Oliver A; Martínez-Martínez L;
Antimicrob Agents Chemother; 2012 Apr; 56(4):1703-13. PubMed ID: 22290967
[TBL] [Abstract][Full Text] [Related]
40. Characterization of carbapenem resistance mechanisms and integrons in Pseudomonas aeruginosa strains from blood samples in a French hospital.
Rojo-Bezares B; Cavalié L; Dubois D; Oswald E; Torres C; Sáenz Y
J Med Microbiol; 2016 Apr; 65(4):311-319. PubMed ID: 26838942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
